WIXLIB

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct NameProductTypeCurrentLotPrevious Lot(VUD)1096790Active( )-Catechin (25 mg)R13070R067H0 (31OCT-2021)1236620Active(-)-Epicatechin (50mg)1236700Active(-)-Epigallocatechin3-O-gallate (20 mg)1666006Active(E)-Thiothixene 148Active(R)-ClopidogrelCarboxylic Acid (10mg) ridin-5(4H)yl)acetic acid)(S)-GlycidylPhthalimide (25 Z)-N'Methylmeloxicam (30mg) 2-methyl-2Hbenzo[e][1,2]thiazine3-carboxamide 1,1dioxide)1,2-Dinitroglycerin (2ampules x 1 ity1213159Active1,3-Dinitroglycerin (2ampules x 1 mL)1570483Active1,3-Propanediol (1mL)1056504Active1,4-Benzoquinone(200 mg)1081750Active1,4-ButanedisulfonicAcid (120 mg)F09990CAS #NDC #UnitPriceCo. OfOriginMaterialOriginUN #NetWeight154-23-4N/A 247.00INPlant25UnitOfMeasuremgCommodityCodes(HS SEligible490-46-0N/A oNoR088T0G0L208 (30SEP-2019)989-51-5N/A 232.00DEPlant20mg2932996560VIALNoNoR143M0H (31-DEC2020)3313-27-7N/A 67S032475750-8N/A 6016159647-0N/A 249114565636-5N/A ferenceStandardReferenceF091V0621-65-8N/A NoYesF091U0623-87-0N/A NoYes1mL2905390000AMPULEYesYesR151J0F0H434 (28FEB-2022)504-63-2N/A 278.00USChemicalSynthesisR15690R06861 (28FEB-2023)106-51-4N/A NoNo27665-390N/A NoNoF132S0Page 1BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct Name1616008Active1,4-Sorbitan (300 mg)1035300Active1,6-anhydro-Dglucose (50 mg)1081807Active1-Butanol (1.2mL/ampule; 3ampules)1265739Active1-Ethoxy-2Methylpropane (3 x0.2 mL)1445571Active1-Mononitroglycerin(2 ampules x 1 mL)1504955Active1-Pentanol (1.2mL/ampule; 3ampules)1570406Active1-Propanol (1.2mL/ampule; -Formylfolic Acid(25 mg) (L-Glutamicacid, ate (25 roxystearicAcid (200 ious Lot(VUD)R108L0R020Y0 (31OCT-2020)CAS #NDC #UnitPriceCo. OfOriginMaterialOriginUN #NetWeightUnitOfMeasureCommodityCodes(HS SEligible27299-123N/A 8-07-7N/A 36-3N/A F06690627-02-1N/A F091T0624-43-1N/A NoYesF0G227R048N0G0M154 (30APR-2019)UN1120R156N0F0E214 (30APR-2022)71-41-0N/A LENoNoR04060G0K306 (31AUG-2019)71-23-8N/A LENoNoR141C0R02850 (31MAR-2022)134-05-4N/A 917494-3N/A -14-9N/A 289.00INPlant200mg2918195000VIALNoNo131918-N/A 138Q0F174W0F0I109 (31MAR-2022)Page 2BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP 1270Active1A01280ActiveProduct NameProductTypePrednisolone-14-ene(25 ne)16Alpha-HydroxyPrednisolone-14-eneAcetate (25 mg) etate)16Alpha-HydroxyPrednisolone-9(11)ene (25 pha-HydroxyPrednisolone-9(11)ene Acetate (25 o-3Hcyclopenta[a]phenanthren-17-yl)-2oxoethyl acetate)16Alpha-HydroxyPrednisolone-9(11)ene Diacetate (25mg) lyticalImpurityCurrentLotPrevious Lot(VUD)CAS #NDC #UnitPriceCo. OfOrigin73-5MaterialOriginUN #NetWeightUnitOfMeasureCommodityCodes(HS F175M013191872-4N/A harmaceuticalAnalyticalImpurityF175D039672-769N/A rmaceuticalAnalyticalImpurityF174X077017-200N/A harmaceuticalAnalyticalImpurityF174Y095943-956N/A age 3BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP 0880Active1A00470ActiveProduct -yl)-2oxoethyl acetate)16Alpha-Hydroxy-11keto Prednisolone 1(6H)dione)16Alpha-Hydroxy-11keto PrednisoloneAcetate (25 mg) oethyl acetate)16alphaHydroxyprednisolone(25 anthren-3-one)17-OxoDexamethasone cahydro-3H-ProductTypeCurrentLotPrevious Lot(VUD)CAS #NDC #UnitPriceCo. rityF175P03754-05-0N/A mpurityF175N03949-79-9N/A 1-707N/A 1-1N/A 400.00UnitOfMeasureCommodityCodes(HS Page 4UN ORUSEligibleBaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct aDihydroequilin (50mg) etrahydroxystilbene2-O-Beta-DGlucoside (50 Dglucopyranoside)2,3-Butanedithiol (3 x1 Active2,4-Disulfamyl-5Trifluoromethylaniline(50 mg)1009479Active2-Acetylpyridine (1 g)1022808Active2-Amino-5chlorobenzophenone(25 mg)1081829Active2-Butanol (1.2mL/ampule; ide (25mg) methylaniline(50 mg)2,4,6Tritertbutylphenol (25mg) (2,4,6-Tri-tertbutylphenol)2,4-Dichlorophenol(100 mg)ProductTypeCurrentLotPrevious Lot(VUD)ReferenceStandardJ1L148J0L148 (30JUN-2017)ReferenceStandardCAS #NDC #UnitPriceCo. OfOriginMaterialOriginUN #NetWeightUnitOfMeasureCommodityCodes(HS SEligible651-55-8N/A 9F082373-942N/A /A 54075804-283N/A eferenceStandarF0M28687-59-2N/A ENoNoF149D0732-26-3N/A oNoF0E113120-83-2N/A NoNo654-62-6N/A 2-62-9N/A H0H040 (31OCT-2014)F0K307R150B0J0F197 (31JUL-2022)719-59-5N/A 877.00CNChemicalSynthesisR09520R006S0 (30APR-2020)78-92-2N/A 257.00JPChemicalSynthesisPage 5UN3336UN1120BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct NameProductTypeCurrentLotPrevious Lot(VUD)CAS #NDC #UnitPriceCo. OfOriginMaterialOriginUN #NetWeightUnitOfMeasureCommodityCodes(HS Ethylhexan-1-ol(1.5 mL)1437053Active2-Methyl-1-propanol(1.2 mL/ampule; 3ampules)1445584Active2-Mononitroglycerin(2 ampules x 1 mL)1A00560Active1A00570Active1570428Active2-Oxo Clopidogrel(Mixture ofDiastereomers) (10mg) (methyl [3,2c]pyridin-5(4H)yl)acetate)2-Oxo R-Clopidogrel(10 mg) (methyl hieno[3,2c]pyridin-5(4H)yl)acetate)2-Propanol (1.2mL/ampule; 3ampules)1570439Active2-Propanol SystemSuitability (3 x 1 thyl)amino5]chlorobenzophenone(25 mg)2-tert-Butyl-4hydroxyanisole (200mg)1171207Active23-EPI-26Deoxyactein (20 mg)1305507Active2E, 4E-HexadienoicAcid Isobutylamide(25 N/A 266.00USChemicalSynthesis78-83-1N/A LENoNoF091S0620-12-2N/A NoYesF168C010990427-0N/A rmaceuticalAnalyticalImpurityF167R0136092354-1N/A 48P0I0L393 (31MAR-2019)67-63-0N/A LENoNoR063N0F0J171 (30NOV-2019)N/AN/A YesNoG0K028F (30-APR2012)N/AN/A 7460L2E348 (31AUG-2019)88-32-4N/A 14B0R03180 (30APR-2020)50193801-8N/A 1,014.00CNPlant20mg2938900000VIALNoNoR13410F0C353 (30JUN-2021)65937-497N/A 9D0F0E212 (31MAR-2017)Page 6BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct hromycin(25 thromycin;(Aminoazithromycin)(25 mg)3'De(dimethylamino)3'-oxoazithromycin(25 ulfonyl]azithromycin (25 mg)1076261Active3-Acetyl-11-KetoBeta-Boswellic Acid(20 mg)1026605Active3-Amino-2,4,6triiodobenzoic Acid(50 mg)1064058Active3-Benzyl-4Heptanone (5 x 0.5mL)1112299Active3-Chlorobenzoic Acid(25 yDesloratadine (25mg) methylpropanoic Acid1,2DiphenylethylamineSalt (75 mg)3-Methyl-1-butanol(1.2 mL/ampule; 3ampules)1430509Active3-OMethylmethyldopa(50 otPrevious Lot(VUD)CAS #NDC #UnitPriceCo. OfOriginMaterialOriginUN #NetWeight25UnitOfMeasuremgCommodityCodes(HS Codes)*2934990005F160F0 (30APR-2023)76592771-7N/A 2,364.00F159S0 (28FEB-2023)61206927-9N/A 925-7N/A 3,100.00CNChemicalSynthesis25mgF173Q061206931-5N/A 4990005VIALNoNomg2935909550VIALNoNoR128E0F0J011 (31MAR-2021)67416-619N/A 436.00INPlant Synthetic20mg2918300000VIALNoNoR146H0G (31-OCT2020)3119-15-1N/A 2-37-7N/A 535-80-8N/A 41008-1N/A /AN/A -51-3N/A N/AN/A 428R06920F0M377 StandardReferenceStandarF0E242H0H391H0L022 (30SEP-2017)G-1 (31-MAR2010)Page 7UN1105BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct NameProductTypeCurrentLotPrevious Lot(VUD)CAS #NDC #UnitPriceCo. 32 (31DEC-2017)121-00-6N/A 289.00USChemicalSynthesisR107C0F0M031 (31MAR-2020)4271-30-1N/A 257.00CNChemicalSynthesisR136K0R107R0 (31JUL-2021)123-30-8N/A 263.00INChemicalSynthesisF003D1F003D0 (31DEC-2019)134-85-0N/A mpurityR11400L1J359 (31OCT-2020)4465-65-0N/A dF11520F011J0PharmaceuticalAnalyticF17310UN #NetWeightUnitOfMeasureCommodityCodes(HS IALNoNo 450.00INChemicalSynthesis10mg2934990005VIALNoNoN/A 0-94-1N/A 65823-9N/A 267.00CNPlant35mg2922505000VIALNoNo139105196-9N/A -00-9N/A 1083100Active3-tert-Butyl-4hydroxyanisole (200mg)1019870Active4Aminobenzoylglutamic Acid (50 mg)1021204Active4-Aminophenol 254Active1327157Active4Chlorobenzophenone(30 mg) (4Chlorobenzophenone)4Epianhydrotetracycline Hydrochloride (50mg)4-Fluoro Risperidone(COLD SHIPMENTREQUIRED) (10 ydrochloride (25mg)4-Hydroxyindole (25mg) (1H-Indol-4-ol)1327319Active4-Hydroxyisoleucine(35 mg)1379445Active1A00900Active4-Methoxymeloxicam(30 mg) 1,2-benzothiazine-3carboxamide G0L252F0E160Page 8UN3077UN2512BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct NameProductType1-ethanone (4'Methylacetophenone))4-Nitrobenzoic Acid(50 mg)alImpurity1466572Active1012178Active5'-Adenylic Acid (500mg)1162126Active5'-Cytidylic Acid ino-2,4,6-triiodoNmethylisophthalamicAcid (50 mg)5-Fluoro Risperidone(25 mg) ]pyrimidin-4-one)5-Hydroxy-Ltryptophan (100 hydantoin(100 mg)1211287Active6,6'-Dinicotinic Acid(50 ne Acetate (20 mg) (3oxo-19-nor-17alphapregn-4,6-dien-20-yn17-yl acetate)6-D-Cys Eptifibatide5Hydroxymethylfurfural(50 mg) de(25 ardR120Q0Previous Lot(VUD)CAS #NDC #UnitPriceCo. OfOriginMaterialOriginUN #NetWeightUnitOfMeasureCommodityCodes(HS SEligible62-23-7N/A 510F0J204 (30JUN-2019)61-19-8N/A 09 (31DEC-2019)63-37-6N/A 247.00JPFermentation500mg2934990005VIALNoNoF155C2 (31DEC-2021)2280-89-9N/A 767.0050mg2924296000NoNo119958974-6N/A 0-09-8N/A 52L067-47-0N/A ferenceStandardF1540084272-855N/A 663.00USPlant25mg2938900000VIALNoNoF89-24-7N/A 02001802-30-8N/A 49010676504-2N/A ferenF129M0NAN/A 1,734.INChemical10mg2934990005VIALNoNoF169E0F001D0 (31DEC-2019)Page 9UN2811BaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP roduct NameProductType(10 mg) yclic(1-6)-disulfide)6-HydroxynicotinicAcid (50 mg)ceStandard6-KetonorethindroneAcetate (20 mg) (3,6Dioxo-19-nor-17alphapregn-4-en-20-yn-17yl acetate)6-Methylnicotinic Acid(50 mg)6Beta-HydroxyEthinyl Estradiol TRADIOL (COLDSHIPMENTREQUIRED) (25 lpha,17-triol)6alphaHydroxybudesonide(25 ntLotPrevious Lot(VUD)CAS #NDC #UnitPriceCo. UN #NetWeightUnitOfMeasureCommodityCodes(HS SEligibleSynthesis5006-66-6N/A 3Q043824427-0N/A 1Y03222-47-7N/A 24-288N/A rmaceuticalAnalyticalImpurityF159V027521-342N/A rmaceuticalAnalyticalImpurityF178L057777751-6N/A 164U0F0K176 (31AUG-2016)MaterialOriginF160G0 (31OCT-2022)Page 10Cold ShipmentRequiredBaseControlDrugBaseControl Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct NameProductTypeCurrentLot1A00590Active7-Fluoro Risperidone(COLD SHIPMENTREQUIRED) (10 ,2a]pyrimidin-4-one)8-Bromotheophylline(400 heophylline(200 mg)1424084Active9-Methylacridine 37Active1000485ActiveAbacavir RelatedCompound A (20 ethanol)Abacavir RelatedCompound B (20 opent-2enyl]methanol)Abacavir RelatedCompound C (20 pent-2enyl]methanolhydrochloride)Abacavir RelatedCompound D (20 ne2,6-diamine)Abacavir RelatedCompounds Mixture(15 reoisomersPrevious Lot(VUD)N/AN/A 6N/A 201085-18-7N/A 08L0611-64-3N/A 284 (31OCT-2013)90662651-5N/A 318F0H283 (31OCT-2013)N/AN/A erenceStandardF1L322F0H285 (30SEP-2013)17201579-1N/A eferenceStandardR152H0F0M143 (31JAN-2022)144342169-9N/A erenceStandardReferenceR077P0R039P0 (31AUG-2018)N/AN/A 7N0R044D0 (30APR-2018)N/AN/A 921.00INChemicalSynthesis15mg2933595960VIALNoNoG (31-JAN2019)CAS #NDC #UnitPriceCo. OfOriginMaterialOriginPage 11UN #NetWeightCommodityCodes(HS rol Drug%

Last Updated On:April 11, 2022USP CatalogCatalog#StatusProduct NameMixture (15 mg)1000408ActiveAbacavir Sulfate avir SulfateRacemic (20 mg) pentene-1methanol sulfate(2:1))Abacavir SystemSuitability Mixture (15mg) (A mixturecontaining abacavirsulfate and transabacavir)Abiraterone Acetate(200 mg)1000829ActiveAbiraterone SystemSuitability Mixture (20mg)1000554ActiveAcamprosateCalcium (200 mg)1000565Active1000576ActiveAcamprosate RelatedCompound A (15 mg)(3-aminopropane-1sulfonic acid)Acamprosate RelatedCompound B (20 mg)1000521ActiveAcarbose (200 mg)(COLD e SystemSuitability Mixture (2mg) (COLDSHIPMENTREQUIRED) (Amixture containingacarbose andimpurities A, B, C, D,E, F and G)AcebutololHydrochloride tandardCurrentLotPrevious Lot(VUD)R108M0R028L0 (30JUN-2020)F0G248CAS #NDC #UnitPriceCo. OfOriginMaterialOriginUN #NetWeightUnitOfMeasureCommodityCodes(HS SEligible18806250-2N/A AN/A erenceStandardR066P0F0J097 (30APR-2018)N/AN/A eferenceStandardR078C0F029L0 (29FEB-2020)15422918-2N/A R103B0R065J0 (29FEB-2020)N/AN/A 48477337-736N/A M4993687-18-1N/A 090N/AN/A erenceR080U0F0M160 (31OCT-2019)56180-940N/A NoR138L0F0L204 (30APR-2021)N/AN/A 5N2 (28FEB-2022)34381-685N/A ge 12BaseControlDrugBaseControl Drug%